Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)

NCT03423732 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DRUG: CardioCell
DRUG: Placebos

Sponsor

John Paul II Hospital, Krakow

Collaborators

[object Object]
[object Object]